Trial intelligence / Profile preview

Atorvastatin for severe sepsis in ICU

ACTRN12607000028404Phase 2Completed

Sponsor
Monash University
Start
Jul 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in sepsis comparing Atorvastatin with Placebo (2 arms). Primary endpoint: Change in serum interleukin-6 level. Started Jul 2007; status: completed.

02

Drugs

atorvastatin
03

Conditions

sepsis

Beyond the preview

Go deeper on ACTRN12607000028404.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12607000028404.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call